Jennifer Selever, Ph.D.

Molecular & Human Genetics Baylor College of Medicine, Houston, TX 
"Jennifer Selever"
Mean distance: 106866 (cluster 5)
Cross-listing: Neurotree

BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Patel JM, Swanson J, Ung K, et al. (2019) Sensory perception drives food avoidance through excitatory basal forebrain circuits. Elife. 8
Cassidy RM, Lu Y, Jere M, et al. (2019) A lateral hypothalamus to basal forebrain neurocircuit promotes feeding by suppressing responses to anxiogenic environmental cues. Science Advances. 5: eaav1640
Herman AM, Ortiz-Guzman J, Kochukov M, et al. (2016) A cholinergic basal forebrain feeding circuit modulates appetite suppression. Nature
Covington KR, Brusco L, Barone I, et al. (2013) Metastasis tumor-associated protein 2 enhances metastatic behavior and is associated with poor outcomes in estrogen receptor-negative breast cancer. Breast Cancer Research and Treatment
Selever J, Gu G, Lewis MT, et al. (2011) Dicer-mediated upregulation of BCRP confers tamoxifen resistance in human breast cancer cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 6510-21
Barone I, Brusco L, Gu G, et al. (2011) Loss of Rho GDIα and resistance to tamoxifen via effects on estrogen receptor α. Journal of the National Cancer Institute. 103: 538-52
De Amicis F, Thirugnansampanthan J, Cui Y, et al. (2010) Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells. Breast Cancer Research and Treatment. 121: 1-11
Selever J, Barone I, Lewis MT, et al. (2009) Effect of estrogen receptor-positive progenitor cells on a tamoxifen resistance phenotype in breast cancer cells. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 1042
Barone I, Cui Y, Herynk MH, et al. (2009) Expression of the K303R estrogen receptor-alpha breast cancer mutation induces resistance to an aromatase inhibitor via addiction to the PI3K/Akt kinase pathway. Cancer Research. 69: 4724-32
See more...